Matthew McManus - 01 Feb 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
President - Diag & Spatial Bio
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
01 Feb 2026
Net transactions value
-$106,710
Form type
4
Filing time
03 Feb 2026, 17:04:06 UTC
Previous filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McManus Matthew President - Diag & Spatial Bio 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed. 03 Feb 2026 0001908268

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +4,621 +98% $0.000000 9,356 01 Feb 2026 Direct
transaction TECH Common Stock Tax liability $106,710 -1,665 -18% $64.09 7,691 01 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -4,621 -50% $0.000000 4,620 01 Feb 2026 Common Stock 4,621 Direct F1, F3
holding TECH Performance Restricted Stock Units 2,888 01 Feb 2026 Common Stock 2,888 Direct F1, F2
holding TECH Performance Stock Option (Right to Buy) 7,951 01 Feb 2026 Common Stock 7,951 $68.54 Direct F2
holding TECH Stock Option (Right to Buy) 15,902 01 Feb 2026 Common Stock 15,902 $68.54 Direct F4
holding TECH Performance Restricted Stock Units 15,825 01 Feb 2026 Common Stock 15,825 Direct F1, F5
holding TECH Restricted Stock Units 5,275 01 Feb 2026 Common Stock 5,275 Direct F1, F6
holding TECH Stock Option (Right to Buy) 21,320 01 Feb 2026 Common Stock 21,320 $74.91 Direct F7
holding TECH Performance Restricted Stock Units 19,243 01 Feb 2026 Common Stock 19,243 Direct F1, F8
holding TECH Restricted Stock Units 9,622 01 Feb 2026 Common Stock 9,622 Direct F1, F9
holding TECH Stock Option (Right to Buy) 24,614 01 Feb 2026 Common Stock 24,614 $53.60 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 4,621 restricted stock units vest on 2/1/2026 and 4,620 restricted stock units vest on 2/1/2027.
F4 Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
F5 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 2,637 restricted stock units vest on 8/15/2026 and 2,638 restricted stock units vest on 8/15/2027.
F7 Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F8 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.
F10 Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.